Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEland Oil & Gas Share News (ELA)

  • There is currently no data for ELA

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Eland Oil & Gas Says Opuama-9 Production Exceeded Management Forecasts

Wed, 04th Jul 2018 11:37

LONDON (Alliance News) - Eland Oil & Gas PLC on Wednesday expressed confidence towards the second half after production at Opuama-9 well, located in Nigeria, came in beyond the upper end of management's guidance.

The exploration company said its Opuama-9 well was completed at the end of June with the short string producing from the D1000 reservoir and the long string from the D2000 reservoir.

Following the maximum efficiency rate test, interim production stood at 3,200 barrels of oil per day at short string and 3,800 barrels at long string.

Eland noted that the combined total production of 7,000 barrels exceeded the upper end of its previous estimates, which were in the range of 4,000 to 6,000 barrels.

Meanwhile, at Opuama-10, the company spudded the well at a depth of 3,599 feet. It intends to proceed drilling to 10,200 feet to reach primary targets in D1000 and D5000 reservoirs and secondary targets in the D3500 and D4000 reservoirs.

Eland expects production from Opuama-10 well to total between 4,000 and 6,000 barrels of oil daily.

Overall, the Opuama fields are currently producing a record 25,000 barrels of oil per day, including both strings from Opuama-9. Upon completion of Opuama-10 well, the company expects total oil production to increase to 30,000 barrels daily.

At Opuama-7 well, the company has seen an increased water-cut leading to remedial action to rectify this. A re-entry of Opuama-7 is expected to take place during the coming month, Eland said.

"The completion of Opuama-9, delivering production significantly above our original forecast, contributes to the continued success of the current drilling campaign," said Chief Executive George Maxwell. "We look confidently towards the second half of 2018."

Shares in Eland were trading 3.6% higher at 125.90 pence each on Wednesday.

More News
5 Feb 2014 09:04

Wednesday broker round-up UPDATE

Afren: Westhouse Securities ups target price from 165p to 180p retaining a buy recommendation. Amlin: Nomura lowers target price from 467p to 442p maintaining a neutral rating. ARM Holdings: Jefferies reduces target price from 1300p to 1140p, while keeping a buy recommendation. Deutsche Bank cuts

Read more
5 Feb 2014 08:12

UK MORNING BRIEFING: Insurers In Focus As Stephen Hester Joins RSA

LONDON (Alliance News) - Shares have continued their slide at the open Wednesday, despite a positive close overnight on Wall Street.

Brokers have been taking a look at UK insurers after RSA Insurance sprung a positive surprise late Tuesday by appointing turnaround a

Read more
6 Jan 2014 08:53

Eland Oil & Gas Completes Restoration Work At Opuama In Nigeria

Read more
16 Oct 2013 10:26

Eland Oil & Gas Hits Low As It Pushes Back Opuama Restoration Completion

Read more
18 Sep 2013 07:42

Eland Oil & Gas Doubles Losses As It Develops Towards 1st Production

Read more
10 Sep 2013 08:17

Tuesday broker round-up UPDATE

African Barrick Gold: Investec shifts target price from 135p to 137p, while downgrading from hold to sell. Aquarius Platinum: JP Morgan moves target price from 39p to 49p, while downgrading from neutral to underweight. Citi lowers target price from 66p to 54p and downgrades from buy to neutral. As

Read more
14 Aug 2013 16:04

Eland Oil & Gas faces delays in Nigeria

West African explorer Eland Oil & Gas said it was facing delays to oil production from wells on a project in Nigeria. Eland said it had experienced some delays in contracting services and permits on its OML 40 licence in the West African nation. As a result, first oil production above 2,500 barrel

Read more
30 May 2013 08:19

Thursday broker round-up UPDATE

AMEC: Morgan Stanley reduces target price from 1220p to 1100p and retains an underweight rating. Amlin: JP Morgan takes target price from 360p to 400p maintaining an underweight rating. Brewin Dolphin: Canaccord Genuity raises target price from 230p to 285p and reiterates a buy recommendation. C

Read more
3 May 2013 16:31

London close: US jobs data sends FTSE 100 to seven-week high

The FTSE 100 jumped one per cent higher to a seven-week high on Friday afternoon with stock markets rejoicing as the US jobs report smashed forecasts in April and previous months' data was revised higher. London's benchmark index closed up 61 points (+0.94%) to close at 6,521, a level not seen sinc

Read more
8 Mar 2013 12:16

Eland Oil & Gas proceeding with plans to restore production at two wells

AIM-listed Eland Oil & Gas is proceeding with planning for a rehabilitation and restart of existing production facilities at its OML 40 asset, an operational update has shown. The company also stated that planning for a further field development drilling campaign in 2013 was also progressing. OML

Read more
15 Jan 2013 07:17

Tuesday broker round-up UPDATE

African Barrick Gold: Investec lowers its target price from 526p to 405p, while upgrading from hold to buy. ARM Holdings: Morgan Stanley raises its target price from 725p to 911p, while downgrading to equal-weight. Investec ups target price from 800p to 900p and downgrades from buy to hold. Aurum

Read more
3 Sep 2012 09:08

Shell sells Nigerian assets

Shell, Europe's biggest oil company, has announced the sale of some of its Nigerian assets to Elcrest, a subsidiary of newly-listed AIM energy company Eland Oil and Gas. The company says the divestment of its 30% interest in Oil Mining Lease 40 for $102m in the Niger Delta is part of a strategy to

Read more
31 Aug 2012 09:17

Eland Oil is largest AIM flotation in more than three years

Eland Oil and Gas, an energy firm based in Aberdeen but focused on West Africa, is keen to get cracking on an oil mining lease it has purchased in the Niger delta after making its debut on AIM. The group, which raised £118m (£106.8m net) through a placing of shares at 100p a throw, started trading

Read more
21 Jul 2009 15:01

Losses narrow at Elan

Neuroscience-based biotechnology company Elan remained mired in the red in the second quarter despite a strong performance from the Biopharmaceuticals business and Elan Drug Technologies (EDT). Total revenue in the three months to 30 June rose to $280.9m from $245.6m, while the loss before tax narr

Read more
21 Jul 2009 13:08

TechMARK movers: Elan narrows loss

Irish drug firm Elan saw net losses narrow to $68.2m from $71.5m in the second quarter thanks to a rise in revenues. Revenues were up by 14%, led by a 30% increase in sales from Tysabri and a 10% increase in revenues from EDT. "For the full year 2009, we remain on target to record double-digit re

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.